ArticleTranslational lung cancer research2022

Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk.

Bing-Xi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.